首頁 > 市場調查報告書 > 醫療設備

眼科設備激光

市場調查報告書

商品編碼

1665230

眼科光凝器市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Ophthalmic Photocoagulator Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月17日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球眼科光凝固器市場價值為 1.546 億美元，預計 2025 年至 2034 年期間將以 4.8% 的強勁複合年成長率成長。推動這一成長的主要促進因素包括視網膜疾病患病率的不斷上升、醫療保健基礎設施的擴展以及對移動和家庭醫療保健解決方案的需求不斷成長。

遠距眼科在這項擴展中發揮關鍵作用，使患者，特別是老年人和行動不便的患者，能夠遠端獲得諮詢和小型治療。攜帶式設備與遠距醫療平台的結合，增強了醫療服務不足和農村地區獲得眼科護理的機會，推動了眼科光凝器的普及。此外，非政府組織（NGO）和醫療機構正在利用遠距眼科來提高發展中國家的眼科護理的可近性，進一步推動市場成長。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	1.546億美元
預測值	2.452億美元
複合年成長率	4.8％

全球範圍內向現代生活習慣的轉變，例如久坐不動、不良飲食和肥胖率上升，導致糖尿病和高血壓等慢性病的增加。這些健康問題是糖尿病視網膜病變和高血壓視網膜病變等視網膜疾病的主要風險因素。預計到 2045 年全球糖尿病患者人數將達到 7 億，對雷射光凝固等有效治療的需求將持續上升，從而支持眼科光凝器市場的長期成長。

就產品類型而言，市場分為攜帶式光凝器和獨立式光凝器。獨立式光凝固器目前佔據最大的市場佔有率，2024 年價值為 9,000 萬美元。這些系統具有先進的功能，包括增強的光束穩定性、更廣泛的治療範圍和卓越的冷卻系統，使其成為治療需要長期使用的慢性視網膜疾病的理想選擇。

市場也按最終用戶類別分類，包括醫院、門診手術中心和眼科診所。醫院部門在 2024 年引領市場，預計到 2034 年市場價值將達到 1.135 億美元。

2024 年，美國眼科光凝固器市場價值為 5,500 萬美元。這反過來有望進一步加速北美市場的成長，促進先進眼科技術在醫院和門診環境中的使用。

產業生態系統分析
產業衝擊力
- 成長動力
  - 眼部疾病盛行率上升
  - 提高認知和診斷率
  - 產品技術進步
- 產業陷阱與挑戰
  - 設備成本高且監管要求嚴格
成長潛力分析
監管格局
報銷場景
技術格局
差距分析
波特的分析
PESTEL 分析
未來市場趨勢

第4章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 年至 2034 年

主要趨勢
獨立式光凝固器
攜帶式光凝器

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

主要趨勢
糖尿病視網膜病變
老年黃斑部病變（AMD）
青光眼
視網膜撕裂與脫離
其他應用

第 7 章：市場估計與預測：按波長，2021 – 2034 年

主要趨勢
綠掃描雷射光凝器
黃掃描雷射光凝器
多色掃描雷射光凝器

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

主要趨勢
醫院
門診手術中心
眼科診所

第 9 章：市場估計與預測：按地區，2021 年至 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第10章：公司簡介

ARC Laser
Alcon
Appasamy Associates
Bausch + Lomb
Coherent
IRIDEX
LIGHTMED
Lumenis
Lumibird Medical
MERIDIAN
NIDEK
Phoenix-Micron
Topcon

簡介目錄

Product Code: 12710

The Global Ophthalmic Photocoagulator Market was valued at USD 154.6 million in 2024 and is forecasted to grow at a robust CAGR of 4.8% from 2025 to 2034. Key drivers fueling this growth include the increasing prevalence of retinal diseases, the expansion of healthcare infrastructure, and the rising demand for mobile and home-based healthcare solutions.

Ophthalmic Photocoagulator Market - IMG1

Tele-ophthalmology plays a pivotal role in this expansion, enabling patients, especially the elderly and those with limited mobility, to access consultations and minor treatments remotely. The integration of portable devices with telemedicine platforms is enhancing access to eye care in underserved and rural regions, driving the adoption of ophthalmic photocoagulators. Furthermore, non-governmental organizations (NGOs) and healthcare institutions are using tele-ophthalmology to improve eye care accessibility in developing countries, further propelling the market growth.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$154.6 Million
Forecast Value	$245.2 Million
CAGR	4.8%

The global shift toward modern lifestyle habits, such as sedentary behavior, poor diets, and rising obesity rates, is contributing to the increase in chronic conditions like diabetes and hypertension. These health issues are major risk factors for retinal diseases, such as diabetic retinopathy and hypertensive retinopathy. With the global diabetic population expected to reach 700 million by 2045, the demand for effective treatments like laser photocoagulation will continue to rise, supporting the ophthalmic photocoagulator market's long-term growth.

In terms of product types, the market is segmented into portable and standalone photocoagulators. The standalone segment currently holds the largest market share, valued at USD 90 million in 2024. Standalone photocoagulators are preferred in high-demand healthcare settings like hospitals and ophthalmology centers. These systems offer advanced features, including enhanced beam stability, broader treatment ranges, and superior cooling systems, making them ideal for treating chronic retinal diseases that require prolonged usage.

The market is also divided by end-user categories, including hospitals, ambulatory surgery centers, and ophthalmology clinics. The hospital segment led the market in 2024, with a projected market value of USD 113.5 million by 2034. Hospitals remain the primary location for complex ophthalmic procedures, as they are equipped to provide specialized care, especially for high-risk retinal conditions.

The U.S. ophthalmic photocoagulator market was valued at USD 55 million in 2024. The country's favorable reimbursement policies, particularly through Medicare, are making laser treatments more accessible, especially for older adults who are more likely to suffer from retinal diseases. This, in turn, is expected to further accelerate market growth in North America, promoting the use of advanced ophthalmic technologies in hospitals and outpatient settings.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of eye disorders
  - 3.2.1.2 Increasing awareness and diagnosis rates
  - 3.2.1.3 Technological advancements in products
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High device cost and stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Standalone photocoagulators
5.3 Portable photocoagulators

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Diabetic retinopathy
6.3 Age-related macular degeneration (AMD)
6.4 Glaucoma
6.5 Retinal tears and detachments
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Wavelength, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 Green scan laser photocoagulator
7.3 Yellow scan laser photocoagulator
7.4 Multicolor scan laser photocoagulator

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgery centers
8.4 Ophthalmology clinics

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE